-
Interglobe Aviat
4,900.30 3,894.80(%) -
Infosys
1,118.55 984.00(%) -
IFCI
96.67 95.75(%) -
Hero Motocorp
5,169.00 4,671.55(%) -
Coal India
422.35 490.90(%) -
Bharat Forge
2,006.00 1,105.45(%) -
Havells India
1,184.00 1,123.85(%) -
TVS Motor Co.
4,065.00 3,228.00(%) -
HDFC Bank
700.15 698.50(%) -
Shreeji Ship. Gl
654.65 704.90(%) -
Milky Mist Dairy
255.10 233.95(%) -
SBI
1,022.00 802.65(%) -
Symbiotec Pharma
1,161.65 1,173.80(%) -
Dhoot Transmission
1,593.30 1,673.50(%) -
Meesho
209.90 254.65(%) -
Lupin
2,137.95 1,881.80(%) -
Tempsens Instruments
588.70 635.00(%) -
Ather Energy
1,702.95 445.60(%) -
Cupid
282.00 298.95(%) -
T B Z
430.40 366.50(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- PPI
- BSE Code : 2393.0
- ISIN : INE107F01022
-
Today’s Low
249.65 -
Today’s High
255.75
-
Open
252.70 -
Perv Close
254.10 -
52W Low
161.50 -
52W High
358.85
Key Indicators
-
P/E(TTM)
14.97
-
Mar.Cap (₹Cr.)
889.56
-
Div & Yield %
0.00
-
Book Value(₹)
41.32
-
Debt-Equity Ratio
0.12
-
AGM Date
01-Sep-2026
-
EPS
16.97
-
P/E Ratio
14.97
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
889.56
-
RONW (%)
49.77
-
ROCE (%)
33.46
Score Board
-
Equity (₹ in Cr.)
34.97
-
BV (₹)
41.30
-
Sales( ₹ in Cr.)
650.27
-
NP (in Cr.)
69.70
-
NP Var(%)
139.0
-
Div%
0.0
-
CPS (₹)
24.00
-
EPS (₹)
19.90
-
Traded Value (₹ in Lakhs)
888.33
-
52 Week High
358.85
-
52 Week Low
161.50
-
Price BSE
254.0
-
Price NSE
254.00
-
Market Capital( in Cr.)
888.33
-
P/C Ratio
10.60
-
P/E Ratio
12.70
-
Price Vs.BV
19.90
-
30-Jul-2026( 11:00)
Corporate News - Wanbu... - Wanbury Limited announced on J...
-
21-Jul-2026( 01:12)
Corporate News - USFDA... - Wanbury announced that a routi...
-
21-Jul-2026( 09:31)
Hot Pursuit - Wanbu... - <p>Wanbury Ltd lost 6.43% toda...
-
15-Jul-2026( 09:30)
Hot Pursuit - Wanbu... - <p>Wanbury Ltd gained 3.27% to...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 599.51 | 577.74 | 499.65 | 511.19 | 392.52 | 367.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 599.51 | 577.74 | 499.65 | 511.19 | 392.52 | 367.45 |
| Other Income | 3.49 | 0.90 | 0.91 | 77.88 | 2.40 | 83.78 |
| Stock Adjustments | -1.51 | 3.89 | -29.13 | 24.79 | 7.20 | -5.99 |
| Total Income | 601.49 | 582.53 | 471.43 | 613.86 | 402.12 | 445.24 |
| EXPENDITURE : | ||||||
| Raw Materials | 292.96 | 307.48 | 274.31 | 325.07 | 228.53 | 169.75 |
| Power and Fuel Cost | 24.24 | 25.17 | 20.59 | 18.41 | 17.13 | 15.38 |
| Employee Cost | 104.24 | 86.92 | 81.00 | 74.81 | 64.15 | 67.48 |
| Other Manufacturing Expenses | 13.76 | 13.32 | 11.43 | 12.66 | 9.98 | 13.77 |
| Selling and Administration Expenses | 64.78 | 58.71 | 45.16 | 55.34 | 45.49 | 55.36 |
| Miscellaneous Expenses | 21.71 | 17.93 | 15.45 | 14.36 | 16.42 | 16.29 |
| Employee Benefit Expenses | 104.24 | 86.92 | 81.00 | 74.81 | 64.15 | 67.48 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 521.69 | 509.54 | 447.94 | 500.65 | 381.70 | 338.02 |
| Operating Profit | 79.81 | 72.99 | 23.49 | 113.19 | 20.42 | 107.23 |
| Interest | 36.95 | 29.18 | 21.39 | 20.61 | 23.07 | 32.87 |
| Gross Profit | 42.86 | 43.81 | 2.10 | 92.58 | -2.65 | 74.36 |
| Depreciation | 13.31 | 13.03 | 12.38 | 11.45 | 9.75 | 9.68 |
| Profit Before Tax | 29.55 | 30.78 | -10.28 | 81.13 | -12.40 | 64.68 |
| Current Tax | 5.86 | 0.00 | 0.00 | 0.00 | 2.27 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -6.84 | 0.38 | 0.11 | -0.35 | -2.07 | 0.21 |
| Reported Net Profit | 30.53 | 30.40 | -10.40 | 81.47 | -12.61 | 64.46 |
| Extraordinary Items | 1.37 | 0.49 | -0.31 | 76.06 | 1.21 | 82.62 |
| Adjusted Net Profit | 29.16 | 29.91 | -10.09 | 5.41 | -13.82 | -18.16 |
| Adjustment below Net Profit | -0.38 | -0.59 | 0.26 | 0.80 | -0.44 | -0.46 |
| P & L Balance brought forward | -138.34 | -168.14 | -158.01 | -240.28 | -227.23 | -291.23 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -108.19 | -138.34 | -168.14 | -158.01 | -240.28 | -227.23 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 9.32 | 9.28 | -3.18 | 24.94 | -5.04 | 25.79 |
| Earnings Per Share(Adj)-Unit Curr | 9.32 | 9.28 | -3.18 | 24.94 | -5.04 | 25.79 |
| Book Value | 16.26 | 6.70 | -2.26 | 0.57 | -52.23 | -47.14 |
| Book Value(Adj)-Unit Curr | 16.26 | 6.70 | -2.26 | 0.57 | -52.23 | -47.14 |
